Retatrutide

🧬 Clinical Overview

This content is provided for educational purposes only and is not intended as advertising or a guarantee of outcomes. Treatment eligibility, dosing, and protocols are determined solely by a licensed medical provider after individualized clinical review.

What it is:

Retatrutide is an investigational metabolic peptide used in provider-guided weight management and metabolic support. Unlike single- or dual-agonist therapies, Retatrutide targets three key metabolic receptors — GLP-1, GIP, and glucagon receptors — and is designed to support appetite regulation, metabolic function, and energy balance under medical supervision. It may be considered for patients seeking alternative metabolic support options as part of a clinically guided program.

Mechanism of Action:

GLP-1 Receptor Agonism: Supports appetite regulation, slows gastric emptying, and assists with glycemic control.

GIP Receptor Agonism: Supports insulin signaling and metabolic efficiency.

Glucagon Receptor Agonism: Supports energy expenditure and fat metabolism pathways.